Healthpeak reports Q2 EPS $0.21, raises FY guidance, $1.2B YTD dispositions

HEALTHPEAK PROPERTIES, INC.

2024-Q2 EPS reported $0.23 revenue$1,302,064,000

Net income diluted $0.21/share in Q2 2024 vs $0.09 in Q2 2023; Nareit FFO $0.44, FFO as Adjusted $0.45, AFFO $0.39.
Increased full-year 2024 diluted EPS guidance to $0.27–$0.31; raised FFO as Adjusted and AFFO guidance midpoints by $0.01 each.
Closed $853M outpatient medical sales at 6.8% trailing cash cap rate in Q2; $1.2B YTD dispositions at ~6.5% cap rate.
Repurchased 4.6M shares for $88M at $19.09 during Q2; YTD 10.5M shares for $188M at $17.98.
Same-store cash NOI growth 4.5%; new dividend $0.30/share payable Aug 16, record Aug 5.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.